Aimmune Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
11,951.00
2,269.00
191,835.00
248,931.00
182,430.00
303,932
Other Current Assets
120.00
106.00
5,622.00
2,749.00
6,681.00
8,687
Total Current Assets
12,071.00
2,375.00
197,457.00
251,680.00
189,111.00
312,619
Net Property, Plant & Equipment
60.00
87.00
2,702.00
10,391.00
17,205.00
26,328
Total Investments and Advances
-
40.00
7,992.00
33,602.00
-
-
Other Assets
25.00
29.00
4,210.00
3,116.00
618.00
608
Total Assets
12,156.00
2,531.00
212,361.00
298,789.00
206,934.00
339,555
ST Debt & Current Portion LT Debt
-
-
-
-
14.00
Accounts Payable
-
-
-
-
5,095.00
Other Current Liabilities
519.00
1,804.00
5,098.00
11,450.00
21,490.00
Total Current Liabilities
519.00
1,804.00
5,098.00
11,450.00
26,599.00
Long-Term Debt
-
-
-
-
77.00
Other Liabilities
-
56.00
1,012.00
1,367.00
2,453.00
Total Liabilities
519.00
1,860.00
6,110.00
12,817.00
29,129.00
Common Equity (Total)
5,291.00
16,257.00
206,251.00
285,972.00
177,805.00
Total Shareholders' Equity
11,637.00
671.00
206,251.00
285,972.00
177,805.00
Total Equity
11,637.00
671.00
206,251.00
285,972.00
177,805.00
Liabilities & Shareholders' Equity
12,156.00
2,531.00
212,361.00
298,789.00
206,934.00
Preferred Stock (Carrying Value)
16,928.00
16,928.00
-
-
-
About Aimmune Therapeutics
View Profile
